Literature DB >> 11145529

Use of anthrax vaccine in the United States.

.   

Abstract

These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11145529

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN： 1057-5987


  12 in total

1.  Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.

Authors:  Joseph A Bellanti; Feng-Ying C Lin; Chiayung Chu; Joseph Shiloach; Stephen H Leppla; German A Benavides; Arthur Karpas; Mahtab Moayeri; Chunyan Guo; John B Robbins; Rachel Schneerson
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

2.  Vaccine strategies of meningococcal disease: results of a 10-year population-based study.

Authors:  Ariane Biebl; Gabriele Hartmann; Christian Bernhard; Elmar Bechter; Anita Luckner-Hornischer; Martin Frühwirth; Sigrid Heuberger; Felix Offner; Verena Barbieri; Burkhard Simma
Journal:  Eur J Pediatr       Date:  2005-08-27       Impact factor: 3.183

3.  Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.

Authors:  Maria I Solano; Adrian R Woolfitt; Anne E Boyer; Renato C Lins; Katie Isbell; Maribel Gallegos-Candela; Hercules Moura; Carrie L Pierce; John R Barr
Journal:  Analyst       Date:  2019-03-25       Impact factor: 4.616

4.  Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines.

Authors:  Benedikt A Aulinger; Michael H Roehrl; John J Mekalanos; R John Collier; Julia Y Wang
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Stable dry powder formulation for nasal delivery of anthrax vaccine.

Authors:  Sheena H Wang; Shaun M Kirwan; Soman N Abraham; Herman F Staats; Anthony J Hickey
Journal:  J Pharm Sci       Date:  2011-09-08       Impact factor: 3.534

Review 6.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

7.  Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel.

Authors:  Darrell E Singer; Rachel Schneerson; Christian T Bautista; Mark V Rubertone; John B Robbins; David N Taylor
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

8.  Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques.

Authors:  Anne E Boyer; Conrad P Quinn; Alex R Hoffmaster; Thomas R Kozel; Elke Saile; Chung K Marston; Ann Percival; Brian D Plikaytis; Adrian R Woolfitt; Maribel Gallegos; Patrick Sabourin; Lisa G McWilliams; James L Pirkle; John R Barr
Journal:  Infect Immun       Date:  2009-06-08       Impact factor: 3.441

Review 9.  Bioterrorism and the nervous system.

Authors:  M H Han; J R Zunt
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 6.030

10.  Biochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames).

Authors:  Rafael M Couñago; Milya Davlieva; Ulrich Strych; Ryan E Hill; Kurt L Krause
Journal:  BMC Struct Biol       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.